BCL2 and B-cell non-Hodgkin lymphoma: The Bcl-2 inhibitor, venetoclax, is a BH-3 mimetic compound and is a potent inhibitor of Bcl-2 function, resulting in apoptosis of aberrant B-cell lymphoma cells [42].